Source Link
Excerpt:
Leading oncology scientists in Brazil have just announced a major breakthrough in the fight against cancer.
A team of scientists at Universidade Federal do Rio Grande do Sul (UFRGS) has discovered that ivermectin nanoparticles destroy cancer cells, massively reducing tumors.
In a groundbreaking preclinical study, researchers led by Drs. Maiara Callegaro Velho and Ruy Carlos Ruver Beck showed that a nano-encapsulated form of ivermectin, when delivered intranasally, reduced glioma tumor volume in rats by over 70%.
The discovery is being hailed as a major development in the fight against glioblastoma, one of the deadliest forms of brain cancer.
The results of the study were published in ACS Biomaterials Science & Engineering.
This is the first study to investigate “nose-to-brain IVM delivery using nanotechnology,” the authors noted.
The team tested two ivermectin nanoformulations:
• IVM-NC: Ivermectin encapsulated in poly(ε-caprolactone) nano capsules
• IVM-MCM: Ivermectin within mesoporous silica particles
